Trevi Therapeutics, Inc. TRVI Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Trevi Therapeutics, Inc.’s reported figures.
The official record: Trevi Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Trevi Therapeutics, Inc.'s enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Trevi Therapeutics, Inc.'s enterprise value?
- Trevi Therapeutics, Inc. (TRVI) reported enterprise value of $1.51B in Q1 2026.
- How has Trevi Therapeutics, Inc.'s enterprise value changed year-over-year?
- Trevi Therapeutics, Inc.'s enterprise value increased by 156.6% year-over-year, from $589.71M to $1.51B.
- What is the long-term trend for Trevi Therapeutics, Inc.'s enterprise value?
- Over 5 years (2020 to 2025), Trevi Therapeutics, Inc.'s enterprise value has grown at a 271.4% compound annual growth rate (CAGR), from $2.25M to $1.59B.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.